ReP USP - Resultado da busca

Artigo de periodico
NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia (2021)
Pereira, Daniela A.; Sandrim, Valeria C.; Palei, Ana C.; Amaral, Lorena M.; Belo, Vanessa A.; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo ; Luizon, Marcelo R.
Source: Pharmacogenomics. Unidades: EERP, FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), CITOCINAS, ÓXIDO NÍTRICO, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Daniela A. et al. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 22, n. 8, p. 451-464, 2021Tradução . . Disponível em: https://doi.org/10.2217/pgs-2021-0006. Acesso em: 02 nov. 2024.
APA
Pereira, D. A., Sandrim, V. C., Palei, A. C., Amaral, L. M., Belo, V. A., Lacchini, R., et al. (2021). NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 22( 8), 451-464. doi:10.2217/pgs-2021-0006
NLM
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Vancouver
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Artigo de periodico
Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes (2021)
Amaral, Lorena M.; Sandrim, Valeria C.; Kutcher, Matthew E.; Spradley, Frank T.; Cavalli, Ricardo de Carvalho ; Tanus-Santos, José Eduardo ; Palei, Ana C.
Source: International Journal of Molecular Sciences. Unidade: FMRP
Subjects: BIOMARCADORES, DNA, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA, COMPLICAÇÕES NA GRAVIDEZ, ESPECTROMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Lorena M. et al. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes. International Journal of Molecular Sciences, v. 22, n. 2, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22020564. Acesso em: 02 nov. 2024.
APA
Amaral, L. M., Sandrim, V. C., Kutcher, M. E., Spradley, F. T., Cavalli, R. de C., Tanus-Santos, J. E., & Palei, A. C. (2021). Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes. International Journal of Molecular Sciences, 22( 2), 1-16. doi:10.3390/ijms22020564
NLM
Amaral LM, Sandrim VC, Kutcher ME, Spradley FT, Cavalli R de C, Tanus-Santos JE, Palei AC. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 2): 1-16.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms22020564
Vancouver
Amaral LM, Sandrim VC, Kutcher ME, Spradley FT, Cavalli R de C, Tanus-Santos JE, Palei AC. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 2): 1-16.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms22020564
Artigo de periodico
Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy (2015)
Luizon, Marcelo R.; Belo, Vanessa A.; Palei, Ana Carolina Taveiros; Amaral, Lorena M.; Lacchini, Riccardo ; Sandrim, Valéria Cristina; Duarte, Geraldo; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo
Source: Hypertension Research. Unidades: EERP, FMRP
Subjects: PRÉ-ECLÂMPSIA, HIPERTENSÃO NA GRAVIDEZ, GESTANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo R. et al. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy. Hypertension Research, v. 38, n. 5, p. 361-366, 2015Tradução . . Disponível em: https://doi.org/10.1038/hr.2015.15. Acesso em: 02 nov. 2024.
APA
Luizon, M. R., Belo, V. A., Palei, A. C. T., Amaral, L. M., Lacchini, R., Sandrim, V. C., et al. (2015). Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy. Hypertension Research, 38( 5), 361-366. doi:10.1038/hr.2015.15
NLM
Luizon MR, Belo VA, Palei ACT, Amaral LM, Lacchini R, Sandrim VC, Duarte G, Cavalli R de C, Tanus-Santos JE. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy [Internet]. Hypertension Research. 2015 ; 38( 5): 361-366.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1038/hr.2015.15
Vancouver
Luizon MR, Belo VA, Palei ACT, Amaral LM, Lacchini R, Sandrim VC, Duarte G, Cavalli R de C, Tanus-Santos JE. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy [Internet]. Hypertension Research. 2015 ; 38( 5): 361-366.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1038/hr.2015.15
Trabalho de evento-resumo
Effects in inhibiting of inducible nitric oxide synthase in the pathophysiology of experimental preeclampsia (2012)
Amaral, Lorena M.; Palei, Ana Carolina T.; Pinheiro, Lucas C.; Sertorio, Jonas T.; Guimarães, Daniele A.; Portela, Rafael L.; Tanus-Santos, José Eduardo
Source: Final Program. Conference titles: High Blood Pressure Research Scientific Sessions (HBPR). Unidade: FMRP
Subjects: PRÉ-ECLÂMPSIA, ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Lorena M. et al. Effects in inhibiting of inducible nitric oxide synthase in the pathophysiology of experimental preeclampsia. 2012, Anais.. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2012. . Acesso em: 02 nov. 2024.
APA
Amaral, L. M., Palei, A. C. T., Pinheiro, L. C., Sertorio, J. T., Guimarães, D. A., Portela, R. L., & Tanus-Santos, J. E. (2012). Effects in inhibiting of inducible nitric oxide synthase in the pathophysiology of experimental preeclampsia. In Final Program. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Amaral LM, Palei ACT, Pinheiro LC, Sertorio JT, Guimarães DA, Portela RL, Tanus-Santos JE. Effects in inhibiting of inducible nitric oxide synthase in the pathophysiology of experimental preeclampsia. Final Program. 2012 ;[citado 2024 nov. 02 ]
Vancouver
Amaral LM, Palei ACT, Pinheiro LC, Sertorio JT, Guimarães DA, Portela RL, Tanus-Santos JE. Effects in inhibiting of inducible nitric oxide synthase in the pathophysiology of experimental preeclampsia. Final Program. 2012 ;[citado 2024 nov. 02 ]
Artigo de periodico
Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy (2012)
Palei, Ana C. T.; Sandrim, Valeria C.; Amaral, Lorena M.; Machado, Jackeline S. R.; Cavalli, Ricardo de Carvalho; Lacchini, Riccardo ; Duarte, Geraldo; Santos, José Eduardo Tanus dos
Source: Basic and Clinical Pharmacology and toxicology. Unidade: FMRP
Subjects: HIPERTENSÃO (FARMACOLOGIA), METALOPROTEINASES, PRÉ-ECLÂMPSIA, GRAVIDEZ, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALEI, Ana C. T. et al. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy. Basic and Clinical Pharmacology and toxicology, v. 111, n. 4, p. 262-267, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1742-7843.2012.00905.x. Acesso em: 02 nov. 2024.
APA
Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Cavalli, R. de C., Lacchini, R., et al. (2012). Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy. Basic and Clinical Pharmacology and toxicology, 111( 4), 262-267. doi:10.1111/j.1742-7843.2012.00905.x
NLM
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Santos JET dos. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 111( 4): 262-267.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00905.x
Vancouver
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Lacchini R, Duarte G, Santos JET dos. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 111( 4): 262-267.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00905.x
Artigo de periodico
Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy (2012)
Palei, Ana C. T.; Sandrim, Valéria C.; Amaral, Lorena M.; Machado, Jackeline S. R.; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Tanus-Santos, José Eduardo
Source: Experimental and Molecular Pathology. Unidade: FMRP
Subjects: HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA, POLIMORFISMO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALEI, Ana C. T. et al. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. Experimental and Molecular Pathology, v. 92, n. 2, p. 217-221, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.yexmp.2012.01.008. Acesso em: 02 nov. 2024.
APA
Palei, A. C. T., Sandrim, V. C., Amaral, L. M., Machado, J. S. R., Cavalli, R. de C., Duarte, G., & Tanus-Santos, J. E. (2012). Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. Experimental and Molecular Pathology, 92( 2), 217-221. doi:10.1016/j.yexmp.2012.01.008
NLM
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Duarte G, Tanus-Santos JE. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy [Internet]. Experimental and Molecular Pathology. 2012 ; 92( 2): 217-221.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.yexmp.2012.01.008
Vancouver
Palei ACT, Sandrim VC, Amaral LM, Machado JSR, Cavalli R de C, Duarte G, Tanus-Santos JE. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy [Internet]. Experimental and Molecular Pathology. 2012 ; 92( 2): 217-221.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.yexmp.2012.01.008

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation